Pancreatic Cancer Research

ResearcherMedical College of WisconsinActive in the last 2 years

Naveen M. Kulkarni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5940-7521; OpenAlex author ID A5032331932. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 4 papers · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 11

  1. Imaging for Early Detection of Pancreatic Ductal Adenocarcinoma: Updates and Challenges in the Implementation of Screening and Surveillance Programs. Co-author DOI 10.2214/ajr.24.31151↗
  2. Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. Co-author DOI 10.1002/jso.27265↗
  3. Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of ab… Co-author DOI 10.1007/s00261-022-03693-0↗
  4. Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. Co-author DOI 10.1016/j.amjsurg.2020.12.001↗
  5. Total Neoadjuvant Therapy for Operable Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-09149-3↗
  6. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC … Co-author DOI 10.1007/s00261-019-02289-5↗
  7. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, upda… Co-author DOI 10.1007/s00261-019-02290-y↗
  8. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cance… Co-author DOI 10.1016/j.surg.2020.04.031↗
  9. Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. Co-author DOI 10.3389/fonc.2020.00460↗
  10. Pancreatic adenocarcinoma: cross-sectional imaging techniques. Co-author DOI 10.1007/s00261-017-1380-4↗
  11. Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis. Co-author DOI 10.1007/s00261-017-1404-0↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mohammed Aldakkak · 6 shared papers, 2018–2023 · strength 0.68
  2. Douglas B. Evans · 6 shared papers, 2018–2023 · strength 0.68
  3. Susan Tsai · 6 shared papers, 2018–2023 · strength 0.68
  4. Kathleen K. Christians · 6 shared papers, 2018–2023 · strength 0.68
  5. Bradley A. Erickson · 5 shared papers, 2020–2023 · strength 0.60
  6. William Adrian Hall · 5 shared papers, 2020–2023 · strength 0.60
  7. Erik V. Soloff · 5 shared papers, 2018–2024 · strength 0.60
  8. Ben George · 5 shared papers, 2020–2023 · strength 0.60
  9. Avinash R. Kambadakone · 5 shared papers, 2018–2024 · strength 0.60
  10. Parag P. Tolat · 5 shared papers, 2018–2023 · strength 0.50
  11. Priya Bhosale · 4 shared papers, 2020–2024 · strength 0.50
  12. Elizabeth M. Hecht · 4 shared papers, 2020–2024 · strength 0.50
  13. Callisia Nathelee Clarke · 4 shared papers, 2020–2023 · strength 0.47
  14. Mandana Kamgar · 3 shared papers, 2020–2023 · strength 0.38
  15. Zhen J. Wang · 3 shared papers, 2020–2023 · strength 0.31
  16. Marc Zins · 3 shared papers, 2020–2023 · strength 0.31
  17. Eric Peter Tamm · 3 shared papers, 2020–2023 · strength 0.31
  18. Olga Rachel Brook · 3 shared papers, 2020–2023 · strength 0.31
  19. Lorenzo Mannelli · 3 shared papers, 2020–2023 · strength 0.31
  20. Michael Hayden Rosenthal · 2 shared papers, 2023–2024 · strength 0.30
  21. Ott Le · 2 shared papers, 2023–2024 · strength 0.30
  22. Samuel Joseph Galgano · 2 shared papers, 2023–2024 · strength 0.30
  23. Lyndon Luk · 2 shared papers, 2023–2024 · strength 0.30
  24. Ajit Harishkumar Goenka · 2 shared papers, 2023–2024 · strength 0.30
  25. Chad A. Barnes · 2 shared papers, 2020 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.